VERA : Insider Transactions for Vera Therapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Vera Therapeutics, Inc. (VERA)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

42,345,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0 - $0

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Vera Therapeutics is a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Co.'s primary product candidate, atacicept, a self-administered fusion protein that blocks both blisibimod and APRIL, is being evaluated for the treatment of immunoglobulin A nephropathy in a global, randomized, double-blind, placebo-controlled clinical trial. Co. has obtained worldwide, exclusive development and commercial rights from Amplyx Pharmaceuticals, Inc., a wholly owned subsidiary of Pfizer Inc., for MAU868, a potentially monoclonal antibody to treat BK viremia infections.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	161,290	161,290	614,507	4,957,633
Total Buy Value	$4,999,990	$4,999,990	$11,881,994	$42,392,668
Total People Bought	1	1	3	8
Total Buy Transactions	1	1	3	27
Total Shares Sold	958,650	2,008,650	2,016,840	2,287,944
Total Sell Value	$39,017,864	$57,917,864	$58,054,276	$63,362,460
Total People Sold	3	4	7	8
Total Sell Transactions	6	7	10	41
End Date	2024-01-21	2023-10-20	2023-04-21	2022-04-21

Adjust Filter Settings

Records found: 111

Page 1 of 5

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Seidenberg Beth C

Director

– • –

2023-03-28

4

B

$7.24

$173,192

I/I

23,908

1,946,995

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-27

4

B

$7.24

$11,830

I/I

1,633

1,923,087

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-24

4

B

$7.24

$13,272

I/I

1,833

1,921,454

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-20

4

B

$7.21

$110,033

I/I

15,252

1,919,621

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-17

4

B

$7.12

$526,882

I/I

74,045

1,904,369

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-16

4

B

$7.09

$426,268

I/I

60,097

1,830,324

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-15

4

B

$7.12

$234,010

I/I

32,844

1,770,227

2.1

-

CHIEF FINANCIAL OFFICER

• – –

2023-03-14

4

GA

$0.00

$0

I/I

14,285

15,277

-

CHIEF FINANCIAL OFFICER

• – –

2023-03-14

4

GD

$0.00

$0

D/D

14,285

35,648

-

Seidenberg Beth C

Director

– • –

2023-03-10

4

B

$7.16

$343,485

I/I

48,003

1,737,383

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-03

4

B

$7.25

$7,245

I/I

1,000

1,689,380

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-02

4

B

$7.24

$169,322

I/I

23,378

1,688,380

2.1

-

Seidenberg Beth C

Director

– • –

2023-03-01

4

B

$7.25

$725

I/I

100

1,665,002

2.02

-

Seidenberg Beth C

Director

– • –

2023-02-23

4

B

$7.24

$1,447

I/I

200

1,664,902

2.02

-

Seidenberg Beth C

Director

– • –

2023-02-13

4

B

$7.20

$72,490

I/I

10,072

1,664,702

2.1

-

Seidenberg Beth C

Director

– • –

2023-02-09

4

B

$7.25

$2,900

I/I

400

1,654,630

2.1

-

Seidenberg Beth C

Director

– • –

2023-02-08

4

B

$7.22

$327,478

I/I

45,357

1,654,230

2.1

-

Seidenberg Beth C

Director

– • –

2023-02-07

4

B

$7.08

$622,728

I/I

87,956

1,608,873

2.1

-

Chief Financial Officer

• – –

2023-02-06

4/A

B

$7.00

$99,995

D/D

14,285

49,933

2.74

-

SVP, Finance, Chief Acct Offcr

• – –

2023-02-06

4/A

B

$7.00

$39,998

D/D

5,714

22,679

2.74

-

Seidenberg Beth C

Director

– • –

2023-02-06

4

B

$7.03

$925,162

I/I

131,602

1,520,917

2.1

-

Longitude Prime Fund, L.p.

10% Owner

– – •

2023-02-06

3

IO

$0.00

$0

I/I

0

1,714,285

-

Tammenoms Bakker Juliet

10% Owner

– – •

2023-02-06

4

B

$7.00

$11,999,995

I/I

1,714,285

1,714,285

1.5

-

Sofinnova Management X-A, L.l.c.

10% Owner

– – •

2023-02-06

4

B

$7.00

$1,999,998

D/D

285,714

3,467,156

2.45

-

Enright Patrick G

Director

– • •

2023-02-06

4

B

$7.00

$11,999,995

I/I

1,714,285

1,714,285

2.25

-

111 Records found	1 2 3 4 5	Page 1 of 5

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.